GameStop Corp. has announced a prospectus supplement under Rule 424(b)(5) for the potential sale of up to 20,000,000 additional shares of its Class A common stock. The shares will be offered through an Open Market Sale AgreementSM with Jefferies LLC, acting as the sales agent. This move follows the previous sale of 120,000,000 shares, which raised approximately $3.1 billion in gross proceeds. The additional shares will be offered from time to time at market prices or through negotiated transactions. The last reported sale price of GameStop's common stock on the NYSE was $24.25 per share as of September 9, 2024. The company has experienced significant volatility in its stock price and trading volume, with fluctuations not directly tied to its financial condition or operational results...Show More

GameStop Corp. has announced a prospectus supplement under Rule 424(b)(5) for the potential sale of up to 20,000,000 additional shares of its Class A common stock. The shares will be offered through an Open Market Sale AgreementSM with Jefferies LLC, acting as the sales agent. This move follows the previous sale of 120,000,000 shares, which raised approximately $3.1 billion in gross proceeds. The additional shares will be offered from time to time at market prices or through negotiated transactions. The last reported sale price of GameStop's common stock on the NYSE was $24.25 per share as of September 9, 2024. The company has experienced significant volatility in its stock price and trading volume, with fluctuations not directly tied to its financial condition or operational results. Investors are cautioned about the potential risk of significant investment loss if the stock price declines post-purchase. The sales agreement allows for sales by any method deemed to be an 'at the market offering' as defined under the Securities Act of 1933. Jefferies LLC will receive a commission of up to 1.5% of the gross sales price per share sold and will act as an underwriter within the meaning of the Securities Act. The date of the prospectus supplement is September 10, 2024.